IMPLANTABLE LOOP RECORDER SERVICES BUSINESS PLAN

I. Executive Summary

Company Description

LoopBridge Cardiology—named to reflect continuous rhythm insight and the connection between patients and clinicians—launches in 2026 as a specialized provider in the cardiovascular diagnostics sector. We focus exclusively on implantation and remote monitoring of subcutaneous implantable loop recorders (ILRs). Our core services pair expert electrophysiologists and nurse practitioners with a lean outpatient implant clinic and a centralized remote-monitoring hub located in a major Texas medical center to serve a large regional patient base. One-liner: continuous rhythm capture, simpler care, faster answers.

We deliver high-efficiency ILR implantation, device programming, event adjudication, and longitudinal remote monitoring, billing as a diagnostic partner to referring physicians. What sets us apart is a tight clinical team, standardized protocols, and a low-overhead outpatient model that preserves >60% operational margin on diagnostics. Target patients are adults with unexplained syncope, palpitations, or cryptogenic stroke risk in the Texas metro region. Short-term goals: open the hub and reach 300 implants in year one. Long-term goals: expand to three regional hubs by 2029 and become the preferred diagnostic partner for 50+ cardiology practices. One-liner: scale a repeatable, margin-rich diagnostic platform.

Problem

Short-term cardiac surveillance misses infrequent arrhythmias. Standard 24–48 hour Holter monitors fail to detect sporadic, potentially life‑threatening events like atrial fibrillation. This leads to delayed diagnoses, missed opportunities to prevent cryptogenic stroke and unexplained syncope, more emergency visits, repeat tests, prolonged patient anxiety, and unclear treatment decisions.

Current care pathways and many clinics lack the infrastructure and focus for continuous, months‑long monitoring. There is a clear gap for a specialized cardiology service that offers implantation and remote monitoring of subcutaneous loop recorders through a lean outpatient model staffed by electrophysiologists and nurse practitioners to deliver reliable, long‑term rhythm capture and actionable clinical insights.

Solution

Millions of Americans with unexplained syncope, palpitations, or cryptogenic stroke need long-term cardiac surveillance that short-term monitors miss; our service provides specialized minimally invasive implantation of subcutaneous loop recorders plus continuous remote monitoring and real-time clinician review to close that diagnostic gap.

We deliver an end-to-end diagnostic pathway: implant by trained clinicians, 24/7 device data monitoring by a dedicated clinical team, immediate alerts for actionable arrhythmias, and concise diagnostic reports to referring physicians—so patients get timely diagnoses and physicians get clear next steps.

Mission Statement

Our mission is to eliminate diagnostic uncertainty for patients with heart rhythm disorders by combining specialized clinical expertise with continuous monitoring technology, so physicians receive clear, actionable insights that accelerate life-saving treatment. We commit to clinical excellence, operational efficiency, and a patient-centric approach that delivers measurable peace of mind. We aim to set the national standard for long-term cardiac monitoring and outpatient procedural care because every patient deserves a definitive answer to unexplained cardiac symptoms.

Key Success Factors

Immediate breakeven through a high‑margin, specialized clinical model supported by scalable operations.

• Immediate breakeven from a high‑margin, specialized implantable loop recorder service.
• Experienced clinical team: 10 practitioners at launch, scaling to 43 by 2030.
• Reliable supply and access via partnerships with device manufacturers and Ambulatory Surgical Centers.
• Proprietary remote monitoring hub with EMR integration for superior data management and reporting.
• Favorable market tailwinds: aging U.S. demographic and reimbursement supportive of remote monitoring.

Financial Summary

Strong early cash generation: Year 1 revenue $21,390,000 with swift payback and high returns.

Funding need: Minimum cash $903,000 (Jan-26); total initial capex $385,000; breakeven Jan-26 and payback in 1 month; reported ROE 369.57% and IRR 0%.

Financial outlook: high-margin, volume-driven model projecting rapid profitability and strong equity returns.

Funding Requirements

The business requires $1,288,000 to reach minimum cash and cover startup capex and working capital; projected Year 1 revenue is $21,390,000 with EBITDA $16,055,000.